NCT Number: NCT00893139
A Study of AL-38583 Ophthalmic Solution 0.05%, 0.010% Versus AL-38583 Vehicle for Dry Eye
The purpose of this study is to determine whether AL-38583 ophthalmic solution is effective for treatment of signs and symptoms of dry eye.
Looking for future studies?
Notify MeKey information
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 2
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Composite corneal staining score of greater than 5 in one or both eyes.
- Schirmer II score of greater than 4 mm.
- OSDI score of greater than 23.
- Other protocol-defined inclusion criteria may apply.
Exclusion criteria
- Any medical condition (systemic or ophthalmic) that may, in the opinion of the investigator, preclude the safe administration of the test article or safe participation in this study.
- Other protocol-defined exclusion criteria may apply.
Treatment and study plan
AL-38583 ophthalmic solution 0.10%
DrugAL-38583 vehicle
DrugInactive ingredients used as a placebo comparator
Primary outcomes
-
Mean change from baseline in sodium fluorescein corneal staining score
Time frame: Baseline, up to Day 35
Secondary outcomes
-
Mean change from baseline in phenol red thread length
Time frame: Baseline, up to Day 35
Interested in participating?
Looking for future studies?
Notify MeSponsors and collaborators
Lead sponsor
Alcon Research
Industry
Registry information
Important dates
- Study start
- 2009
- Primary completion
- 2010
- Study completion
- 2010
- First posted
- May 5, 2009
- Registry last updated
- Jul 15, 2014
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Preliminary Clinical Study of the Effectiveness and Safety of Ocular Surface Microbiota Transplantation in the Treatment of Dry Eye Disease
NCT07298811
Dry Eye, Dry Eye Syndromes
Nanchang, Jiangxi, China
View Trial DetailsDry Eye Screening and Referral System
NCT04413370
Dry Eye, Dry Eye Syndromes
Guangzhou, Guangdong, China
View Trial DetailsProteomics Analysis of Human Tears in the Diagnosis and Management of Dry Eye Disease
NCT07175909
Dry Eye, Dry Eye Disease (DED)
Hong Kong
View Trial DetailsYogic Eye Exercises for Computer Vision Syndrome in Female Design Students
NCT07816419
Arthralgia, Asthenopia
Riyadh, Saudi Arabia
View Trial Details